Cyclosporin A improves the selection of cells transfected with the puromycin acetyltransferase gene.
Sydney Cancer Centre, Royal Prince Alfred Hospital and Faculty of Medicine, University of Sydney, NSW, Australia.
Guoping
G
Zheng
J Guy
JG
Lyons
D000123:Acetyltransferases / Q000235:genetics* / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D016572:Cyclosporine / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005189:False Positive Reactions; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D009361:Neoplasm Invasiveness / Q000235:genetics; D011691:Puromycin / Q000494:pharmacology; D012016:Reference Values; D012641:Selection, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000378:metabolism; D014700:Verapamil / Q000494:pharmacology
D000970:Antineoplastic Agents; D011691:Puromycin; D016572:Cyclosporine; D014700:Verapamil; D000123:Acetyltransferases; C045336:puromycin N-acetyltransferase